
The gap between classroom training and industry practice is pushing analysts toward familiar techniques instead of the most appropriate ones.
Reaching sustainability and efficiency goals simultaneously is possible in RMID, a regulatory-enforced part of (bio)pharmaceutical drug manufacturing.






